NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
73 hedge funds and large institutions have $403M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $533M → $403M (-$131M)
Holders
73
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$12.9M | |
| 2 | +$12.3M | |
| 3 | +$11.1M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$2.82M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.06M |
Top Sellers
| 1 | -$1.33M | |
| 2 | -$1.3M | |
| 3 | -$700K | |
| 4 |
Morgan Stanley
New York
|
-$520K |
| 5 |
Goldman Sachs
New York
|
-$518K |